The Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling is a joint initiative in Germany between the Freie Universität Berlin and the Universität Potsdam, bridging pharmacy and mathematics, supported by the research-driven pharmaceutical companies AbbVie Deutschland GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, F. Hoffmann-La Roche Ltd, Grünenthal GmbH, Merck KGaA and SANOFI.

It offers its graduate students a unique opportunity to experience research in the area of drug development and optimising drug therapy jointly within academia and industry.

The interdisciplinary PhD program is designed as a 3.5 year research program including a structured research training curriculum of advanced academic & industrial modules and a competitive research fellowship. Yearly call for application from July to mid September, to start March the following year.


NOTE FOR APPLICANTS: >> Email notifications to shortlisted and waiting list candidates have been sent out. There will be no further email notifications to all other applicants until shortly after the personal interviews. Please note that we will not be able to answer individual requests regarding the current status of the application process.<<